Cadinha & CO LLC Amgen Inc Transaction History

Cadinha & CO LLC

$595 Million
Q4 2024

A detailed history of Cadinha & CO LLC transactions in Amgen Inc stock. As of the latest transaction made, Cadinha & CO LLC holds 5,217 shares of AMGN stock, worth $1.48 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

5,217

Previous 5,209 0.15%

Holding current value

$1.48 Million

Previous $1.68 Million 19.01%

% of portfolio

0.23%

Previous 0.29%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	BUY	$258.78 - $328.31 $2,070 - $2,626	8 Added 0.15%	5,217 $1.36 Million
Q3 2024 Oct 08, 2024	BUY	$309.38 - $337.38 $9,900 - $10,796	32 Added 0.62%	5,209 $1.68 Million
Q2 2024 Jul 30, 2024	BUY	$262.75 - $319.31 $43,879 - $53,324	167 Added 3.33%	5,177 $1.62 Million
Q4 2023 Jan 24, 2024	SELL	$255.7 - $288.46 $223,737 - $252,402	-875 Reduced 14.87%	5,010 $1.44 Million
Q3 2023 Nov 01, 2023	BUY	$218.65 - $271.46 $212,090 - $263,316	970 Added 19.74%	5,885 $1.58 Million
Q2 2023 Jul 26, 2023	SELL	$214.27 - $253.37 $5.71 Million - $6.76 Million	-26,663 Reduced 84.44%	4,915 $1.09 Million
Q1 2023 Apr 28, 2023	SELL	$225.79 - $275.2 $6.33 Million - $7.71 Million	-28,028 Reduced 47.02%	31,578 $7.63 Million
Q4 2022 Jan 25, 2023	BUY	$229.03 - $291.01 $12 Million - $15.3 Million	52,526 Added 741.89%	59,606 $0
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $258,395 - $287,548	-1,120 Reduced 13.66%	7,080 $1.72 Million
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $260,931 - $288,658	-1,190 Reduced 12.67%	8,200 $1.98 Million
Q4 2021 Feb 03, 2022	SELL	$198.88 - $227.6 $14.4 Million - $16.5 Million	-72,315 Reduced 88.51%	9,390 $2.11 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $224,793 - $263,373	1,059 Added 1.31%	81,705 $17.4 Million
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $265,814 - $294,901	1,138 Added 1.43%	80,646 $19.7 Million
Q1 2021 May 06, 2021	SELL	$221.91 - $258.6 $1.32 Million - $1.54 Million	-5,965 Reduced 6.98%	79,508 $19.8 Million
Q4 2020 Jan 22, 2021	BUY	$216.38 - $257.67 $394,027 - $469,217	1,821 Added 2.18%	85,473 $19.7 Million
Q3 2020 Oct 30, 2020	BUY	$234.65 - $260.95 $338,599 - $376,550	1,443 Added 1.76%	83,652 $21.3 Million
Q2 2020 Jul 22, 2020	BUY	$197.81 - $242.74 $481,469 - $590,829	2,434 Added 3.05%	82,209 $19.4 Million
Q1 2020 May 06, 2020	BUY	$182.24 - $241.7 $13.3 Million - $17.6 Million	72,714 Added 1029.8%	79,775 $16.2 Million
Q4 2019 Jan 23, 2020	BUY	$189.21 - $243.2 $12,298 - $15,808	65 Added 0.93%	7,061 $1.7 Million
Q3 2019 Oct 30, 2019	SELL	$174.11 - $208.62 $42,482 - $50,903	-244 Reduced 3.37%	6,996 $1.35 Million
Q2 2019 Aug 09, 2019	SELL	$166.7 - $195.41 $11.7 Million - $13.8 Million	-70,408 Reduced 90.68%	7,240 $1.33 Million
Q1 2019 May 08, 2019	BUY	$180.87 - $203.88 $328,640 - $370,449	1,817 Added 2.4%	77,648 $14.8 Million
Q4 2018 Jan 29, 2019	BUY	$178.4 - $208.25 $9.52 Million - $11.1 Million	53,345 Added 237.24%	75,831 $14.8 Million
Q3 2018 Nov 07, 2018	BUY	$185.29 - $208.89 $3,705 - $4,177	20 Added 0.09%	22,486 $4.66 Million
Q2 2018 Aug 07, 2018	BUY	$166.05 - $186.51 $1.19 Million - $1.34 Million	7,175 Added 46.92%	22,466 $4.15 Million
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $5.05 Million - $5.91 Million	-29,829 Reduced 66.11%	15,291 $2.61 Million
Q4 2017 Jan 29, 2018	BUY	$168.79 - $188.59 $5.46 Million - $6.1 Million	32,334 Added 252.89%	45,120 $7.85 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $2.14 Million - $2.44 Million	12,786	12,786 $2.38 Million

Others Institutions Holding AMGN

# of Institutions

3,078

Shares Held

404M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadinha & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cadinha & CO LLC with notifications on news.

Account